Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes.

[1]  J. Prinz.  Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis , 2018, Front. Immunol..

[2]  K. Schäkel,et al.  Regulation of IL-22BP in psoriasis , 2018, Scientific Reports.

[3]  F. Kurschus,et al.  IL-17 for therapy. , 2017, Journal of dermatological science.

[4]  Martin M. Schumacher,et al.  Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis , 2015, Experimental dermatology.

[5]  M. Udey,et al.  IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms , 2014, Proceedings of the National Academy of Sciences.

[6]  B. Elewski,et al.  Secukinumab in plaque psoriasis--results of two phase 3 trials. , 2014, The New England journal of medicine.

[7]  Takao Shimizu,et al.  Interplay between CXCR2 and BLT1 Facilitates Neutrophil Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-Induced Psoriasis , 2014, The Journal of Immunology.

[8]  S. Leal,et al.  Autocrine IL-17A–IL-17RC neutrophil activation in fungal infections is regulated by IL-6, IL-23, RORγt and Dectin-2 , 2013, Nature Immunology.

[9]  S. Werner,et al.  Aldara activates TLR7-independent immune defence , 2013, Nature Communications.

[10]  H. Luhmann,et al.  An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. , 2013, The Journal of investigative dermatology.

[11]  J. Ortonne,et al.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.

[12]  A. Waisman.  To be 17 again--anti-interleukin-17 treatment for psoriasis. , 2012, The New England journal of medicine.

[13]  Andrew Johnston,et al.  Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis , 2011, PloS one.

[14]  F. Nestle,et al.  The IL-23/Th17 axis in the immunopathogenesis of psoriasis. , 2009, The Journal of investigative dermatology.

[15]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[16]  C. Sasakawa,et al.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.

[17]  L. Fouser,et al.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. , 2008, The Journal of clinical investigation.

[18]  Scott R. Presnell,et al.  Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F , 2007, The Journal of Immunology.

[19]  I. Mellman,et al.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.

[20]  J. Derry,et al.  Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex , 2006, The Journal of Immunology.

[21]  K. Asadullah,et al.  IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.

[22]  D. Hicklin,et al.  Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[24]  Werner Müller,et al.  Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte‐expressed protein , 2004, Genesis.

[25]  T. Moseley,et al.  Soluble and Transmembrane Isoforms of Novel Interleukin-17 Receptor-like Protein by RNA Splicing and Expression in Prostate Cancer* , 2002, The Journal of Biological Chemistry.

[26]  W. M. Weaver,et al.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. , 2001, Immunity.

[27]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[28]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[29]  M. Seldin,et al.  Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. , 1995, Journal of immunology.

[30]  A. Johnsen,et al.  hCAP‐18, a cathelin/pro‐bactenecin‐like protein of human neutrophil specific granules , 1995, FEBS letters.

[31]  Mark Lebwohl,et al.  Psoriasis , 1906, The Lancet.

[32]  K. Rajewsky,et al.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.